Erchonia Corporation

What Erchonia Corporation does

Erchonia Corporation is a private medical device manufacturer founded in 1996 and headquartered in Melbourne, Florida, specializing in FDA-cleared low-level laser therapy (LLLT) devices, also referred to as cold laser or photobiomodulation. The company's products use specific visible light wavelengths—red (640nm), violet (405nm), and green (520nm)—to excite cellular electrons and stimulate the mitochondrial electron transport chain, increasing ATP production to reduce inflammation and accelerate tissue repair without thermal effects. Its product portfolio spans approximately 10 core SKUs across five clinical categories: fat loss/body contouring (Emerald Laser, Zerona VZ8), pain management (FX 635, FX 405, GVL, EVRL, XLR8), foot fungus treatment (Lunula), and veterinary systems (VLS, EVL, VGL), plus a line of accessories and consumables.

Erchonia generates revenue primarily through one-time hardware sales of capital equipment to healthcare professionals, with quote-based pricing and financing/rental options available. The go-to-market model is direct enterprise field sales targeting physicians, chiropractors, physical therapists, veterinarians, dental professionals, and medical-spa operators, supplemented by an annual Laser Expo, an eCommunity training platform, and a Find a Provider patient-referral directory. The company holds multiple FDA market clearances for specific indications—including chronic low back pain, plantar fasciitis, body circumference reduction, acne vulgaris, and onychomycosis—and maintains ISO 13485, ISO 14971, and CE Mark certifications. Erchonia operates a wholly-owned UK subsidiary (Erchonia Lasers Limited) for European distribution and reports 51-100 employees. The company has no disclosed AI capabilities, no public API, and its technology is purely photonic/biophysical in nature.

Name

Erchonia Corporation

Legal name

Erchonia Corporation

Website

https://erchonia.com

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

51–100 employees

Short description

Erchonia Corporation, founded in 1996 and based in Melbourne, Florida, manufactures FDA-cleared low-level laser therapy devices for fat loss, pain management, dermatology, and veterinary applications, selling direct to healthcare professionals across multiple medical verticals.

Ownership category

akta.pro rank

Product category

Medical Laser Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Laser & Energy-Based Dermatology (HLAKACAF)

akta.pro secondary industries

Rehabilitation & Physical Therapy Devices (Laser, Hydrotherapy, TENS) (HLAMAFAK), Laser Periodontal Therapy (HLABACAJ)

Keywords

• Low-level laser therapy
• Medical laser devices
• Photobiomodulation systems
• Cold laser therapy
• Non-invasive body contouring

Headquarters

HQ city

Melbourne

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Medical Laser Device Sales: Sale of FDA-cleared low-level laser therapy devices to healthcare professionals including handheld units (XLR8, EVRL, GVL, VGL), stationary scanners (FX 635, FX 405, Zerona VZ8), and veterinary systems. Devices are sold directly to clinics, hospitals, and veterinary practices with pricing based on device type and capabilities. The company offers financing options and rental programs for practices.
2. Accessories and Consumables: Sale of laser accessories including therapeutic stands, percussor devices, adjustor devices, base stations for multiple handheld units, and replacement batteries (3.7 VDC Lithium-ion Polymer) for handheld devices
3. Professional Services and Training: Erchonia provides advanced training and marketing resources through their eCommunity platform for product users, including hundreds of courses from industry speakers, marketing materials, and certification programs for practitioners integrating laser therapy into their practices

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Core offering

Erchonia Corporation designs, manufactures, and sells FDA-cleared low-level laser therapy (LLLT / cold laser) devices that use specific visible-light wavelengths (red 640nm, violet 405nm, green 520nm) to stimulate cellular activity, reduce inflammation, and accelerate tissue repair. Its portfolio spans handheld and stationary lasers for chronic pain management (e.g., FX 635, FX 405, GVL, EVRL, XLR8), non-invasive body contouring (Emerald, Zerona VZ8), onychomycosis (Lunula), dermatology, and veterinary applications, sold to healthcare practitioners and clinics.

Product overview

Erchonia Corporation offers a portfolio of FDA-cleared low-level laser therapy (LLLT) devices that use specific wavelengths of visible light to stimulate cellular activity and promote natural healing. The product line spans multiple categories: fat loss lasers (Emerald Laser™, Zerona® VZ8) that create temporary pores in fat cells for non-invasive body contouring; pain management devices (FX 635, FX 405, GVL, EVRL, XLR8®) targeting conditions like chronic low back pain, plantar fasciitis, and musculoskeletal pain; dermatology/acne treatment lasers utilizing violet wavelength's antimicrobial properties; foot fungus treatment (Lunula Laser®); and veterinary systems (VLS, EVL, VGL) for animal care. Accessories include therapeutic stands, percussion devices, and charging bases. The technology operates through photobiomodulation, with wavelengths including red (640nm), violet (405nm), and green (520nm) each targeting different cellular mechanisms and therapeutic outcomes.

Differentiator

Problem solved

Functional benefit

Brands

• Zerona: Non-invasive fat loss laser system using violet laser technology for body contouring treatments
• Emerald Laser
• Lunula Laser
• XLR8
• FX Series
• VGL Vet Laser
• VLS Vet Laser
• EVRL Laser
• EVL Vet Laser
• GVL Laser

Products and services

• Emerald Laser FDA market-cleared low-level laser device for overall body circumference reduction, indicated for patients with a BMI up to 40. Sold to medical spas, weight-loss clinics, and wellness centers for non-invasive body contouring.
• Zerona VZ8 Laser World's first violet fat loss laser using 405nm wavelength technology with 8 laser heads to create temporary pores in fat cells, enabling non-invasive body contouring. Holds FDA market clearance (K231474) and OTC clearance allowing operation without a medical license in clinics, salons, spas, and gyms.
• FX 635 Laser FDA-cleared unattended pain laser scanner and the only low-level laser FDA-cleared to treat chronic low back pain and plantar fasciitis. Uses triple-head, hands-free design with 635nm red wavelength, enabling practitioners to treat other patients during sessions.
• FX 405 Laser Unattended pain laser scanner combining violet (405nm) and red (640nm) wavelengths for hands-free treatment. FDA market-cleared (K231409) for adjunctive temporary relief of nociceptive musculoskeletal pain and adjunctive treatment of postoperative pain.
• GVL Laser First and only FDA-cleared green wavelength laser combining 520nm green and 405nm violet wavelengths. Cord-free, smartphone-sized handheld design. FDA-cleared (K221987) for adjunctive relief of minor chronic neck and shoulder pain and treatment of moderate inflammatory Acne Vulgaris.
• EVRL Laser Red and violet handheld pain laser combining 640nm red and 405nm violet wavelengths. Most popular handheld device offering versatility for a broader range of treatment conditions with anti-bacterial properties. FDA-cleared (K152196) for chronic neck/shoulder pain and acne vulgaris; FDA Class II (US) / Class IIa (EU).
• XLR8 Laser Cord-free handheld low-level laser for portable pain-relief treatments. Designed for easy portability between offices for practitioners offering on-the-go LLLT services.
• Lunula Laser Only FDA-cleared non-thermal, touchless laser for treating onychomycosis (toenail fungus). Provides drug-free treatment without contact or heat, sold to podiatrists and dermatology practices.
• VLS Vet Laser System Handheld veterinary laser system with preset protocols for canine, equine, feline, exotics, and user-programmable channels. Uses red wavelength technology to treat arthritis, soft-tissue injuries, and post-surgical healing in animals.
• EVL Vet Laser System Handheld veterinary laser combining 640nm red and 405nm violet wavelengths for a broader range of treatment options within one device. Targets pain, inflammation, and wound healing in animal patients. CE Marked.
• VGL Vet Laser System First violet-and-green veterinary handheld laser combining 520nm green and 405nm violet wavelengths. Adapted from the human-use GVL for animal care applications. FDA-cleared and CE Marked.
• Percussor Patented therapeutic percussion device designed to work alongside Erchonia laser therapy treatments to enhance therapeutic outcomes.
• Adjustor Portable variable-pulse adjusting device for therapeutic applications, used as a complement to Erchonia laser therapy treatments.
• Laser Stands (PL Series) Hands-free assistant stands for Erchonia handheld laser devices, enabling unattended treatment delivery during clinical sessions.
• Base Station Deluxe charging base station allowing up to three independent Erchonia handheld devices to be charged wirelessly simultaneously; designed for ergonomics, space-saving, and portability across multiple practices.

Quantifiable outcome

• Clients averaged 3.91 inches of fat loss using Zerona VZ8 in double-blind, randomized, multi-site, placebo-controlled study
• +5 more outcomes

Named customers6 records

Segments6 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Sciton: Sciton manufactures high-end aesthetic and medical laser platforms (BBL, Halo, Joule) for dermatologists and plastic surgeons — a broader incumbent overlapping with Erchonia's dermatology/aesthetic laser applications.
• Cutera: Cutera is an established aesthetic laser manufacturer offering body contouring (TruSculpt) and dermatology systems sold into medspas and physician practices — overlapping with Erchonia's aesthetic segment at a larger scale.
• Cynosure (Hologic): Cynosure (now part of Hologic) is a major aesthetic and medical laser manufacturer offering body contouring (SculpSure) and dermatology platforms — a broader incumbent that competes with Erchonia's Zerona VZ8 and Emerald Laser in non-invasive body contouring.
• BTL Industries: BTL is a global medical device leader in non-invasive body contouring (EMSCULPT, Exilis) and pain management (Super Inductive System) — a broader incumbent competing with Erchonia in both aesthetic body contouring and physical therapy/rehabilitation channels.
• Lumenis: Lumenis is a large medical/aesthetic laser company offering platforms across dermatology, surgery, and ophthalmology — competes broadly with Erchonia in dermatology (acne, skin) and overlapping pain/inflammation applications.

Direct peers

• THOR Photomedicine: THOR is a UK-based photobiomodulation/LLLT manufacturer selling medical-grade low-level lasers to clinicians and researchers worldwide — a direct competitor in the same core low-level laser therapy category with overlapping wavelength technology.
• Multi Radiance Medical: Multi Radiance manufactures FDA-cleared LLLT devices combining super pulsed laser, infrared, and visible light wavelengths for pain and rehabilitation — directly comparable to Erchonia's multi-wavelength approach in the same practitioner market.
• LiteCure / Companion Animal Health: LiteCure manufactures FDA-cleared LLLT/cold laser devices for human physical therapy, chiropractic, and veterinary use — the closest direct competitor to Erchonia across pain management and veterinary verticals with overlapping product positioning.
• Aspen Laser: Aspen Laser sells FDA-cleared cold laser/LLLT devices (Summus Platinum, Apex) targeting chiropractors, physical therapists, and pain specialists — a direct competitor in the same practitioner channel with similar handheld and stationary device formats.

Emerging players

• BioLight Technologies: BioLight Technologies is a smaller LLLT/cold laser manufacturer serving wellness and pain markets with portable devices — an emerging player with partial overlap to Erchonia's handheld pain and wellness channels.

Market position

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/erchonia
• YouTubeyoutube.com/erchoniavideo
• Facebookfacebook.com/erchonia
• Instagraminstagram.com/erchonia
• Pinterestpinterest.com/erchonia
• LinkedInlinkedin.com/company/erchonia-corporation

Compliance17 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Erchonia Corporation